Photo by nci from unsplash
(1) Department of Neuro Oncology; Erasmus MC, Rotterdam, the Netherlands (2) Bellaria Hospital, Bologna, Italy, (3) Pitie Salpertiere, Paris, France (4) Addenbrooks Hospital, Cambridge, UK (5) Freiburg, Germany (6) MUMC,… Click to show full abstract
(1) Department of Neuro Oncology; Erasmus MC, Rotterdam, the Netherlands (2) Bellaria Hospital, Bologna, Italy, (3) Pitie Salpertiere, Paris, France (4) Addenbrooks Hospital, Cambridge, UK (5) Freiburg, Germany (6) MUMC, Maastricht (7) MC Haaglanden, Den Haag (8) CHUV, Lausanne, Switzerland (9) Thierry Gorlia, EORTC, Brussels, Belgium (10) Department of Pathology; Erasmus MC, Rotterdam, the Netherlands
Keywords:
primary recurrent;
actionable mutations;
stability actionable;
mutations primary;
oncology;
recurrent glioblastomas
Journal Title: Neuro-oncology
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Neuro-oncology
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!